Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 59 | 2024 | 17349 | 2.340 |
Why?
|
Coronary Artery Disease | 21 | 2020 | 6504 | 1.460 |
Why?
|
Plaque, Atherosclerotic | 13 | 2020 | 1535 | 0.970 |
Why?
|
HIV Integrase Inhibitors | 2 | 2023 | 165 | 0.870 |
Why?
|
Intra-Abdominal Fat | 8 | 2021 | 612 | 0.860 |
Why?
|
Adipose Tissue | 6 | 2020 | 3309 | 0.840 |
Why?
|
Amino Acids | 2 | 2018 | 1703 | 0.700 |
Why?
|
Adiposity | 8 | 2019 | 1879 | 0.690 |
Why?
|
Growth Hormone | 2 | 2010 | 569 | 0.560 |
Why?
|
Anti-HIV Agents | 7 | 2022 | 4526 | 0.540 |
Why?
|
Lipoproteins, LDL | 2 | 2018 | 643 | 0.530 |
Why?
|
HIV | 7 | 2019 | 1581 | 0.470 |
Why?
|
Serum | 1 | 2016 | 208 | 0.470 |
Why?
|
Inflammation | 11 | 2021 | 10758 | 0.470 |
Why?
|
Interleukin-10 | 1 | 2020 | 1176 | 0.460 |
Why?
|
HIV-1 | 6 | 2023 | 6851 | 0.450 |
Why?
|
Fibrosis | 2 | 2018 | 2051 | 0.450 |
Why?
|
Human Growth Hormone | 2 | 2009 | 642 | 0.440 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 834 | 0.420 |
Why?
|
Atherosclerosis | 5 | 2019 | 3405 | 0.420 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 6 | 2019 | 282 | 0.420 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 968 | 0.400 |
Why?
|
Lipids | 5 | 2014 | 3330 | 0.400 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1201 | 0.400 |
Why?
|
Coronary Angiography | 10 | 2019 | 4506 | 0.390 |
Why?
|
RANK Ligand | 1 | 2012 | 318 | 0.360 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 2 | 2008 | 138 | 0.350 |
Why?
|
Aldosterone | 3 | 2015 | 869 | 0.320 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1388 | 0.320 |
Why?
|
Body Composition | 8 | 2019 | 2427 | 0.320 |
Why?
|
Anti-Retroviral Agents | 6 | 2021 | 1784 | 0.310 |
Why?
|
Macrophage Activation | 4 | 2018 | 552 | 0.310 |
Why?
|
Adrenal Glands | 1 | 2010 | 552 | 0.290 |
Why?
|
Calcinosis | 3 | 2012 | 1477 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 3245 | 0.290 |
Why?
|
Adiponectin | 3 | 2008 | 1106 | 0.270 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 609 | 0.270 |
Why?
|
Adipocytes, White | 1 | 2007 | 91 | 0.270 |
Why?
|
Dyslipidemias | 2 | 2011 | 870 | 0.260 |
Why?
|
Middle Aged | 54 | 2024 | 220835 | 0.260 |
Why?
|
Carotid Artery, Common | 1 | 2006 | 175 | 0.250 |
Why?
|
Coronary Vessels | 3 | 2016 | 3111 | 0.240 |
Why?
|
Monocytes | 5 | 2018 | 2570 | 0.240 |
Why?
|
Vitamin D | 1 | 2019 | 3302 | 0.240 |
Why?
|
Receptors, Cell Surface | 6 | 2019 | 2802 | 0.240 |
Why?
|
Asymptomatic Diseases | 5 | 2019 | 588 | 0.240 |
Why?
|
Obesity | 4 | 2019 | 12937 | 0.230 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2007 | 585 | 0.230 |
Why?
|
Blood Proteins | 2 | 2020 | 1172 | 0.230 |
Why?
|
Blood Glucose | 5 | 2019 | 6390 | 0.220 |
Why?
|
Antigens, CD | 6 | 2019 | 4008 | 0.220 |
Why?
|
Arteritis | 2 | 2016 | 158 | 0.210 |
Why?
|
Humans | 73 | 2024 | 761098 | 0.200 |
Why?
|
Interleukin-18 | 2 | 2021 | 250 | 0.200 |
Why?
|
HIV Integrase | 1 | 2023 | 121 | 0.200 |
Why?
|
Viral Load | 7 | 2020 | 3328 | 0.190 |
Why?
|
Prolactinoma | 2 | 2021 | 114 | 0.190 |
Why?
|
Adult | 41 | 2024 | 221083 | 0.190 |
Why?
|
Male | 52 | 2024 | 360675 | 0.180 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2018 | 1932 | 0.180 |
Why?
|
Female | 49 | 2024 | 392458 | 0.180 |
Why?
|
Amygdala | 2 | 2019 | 1354 | 0.180 |
Why?
|
Noise, Transportation | 1 | 2021 | 56 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2021 | 12145 | 0.180 |
Why?
|
Case-Control Studies | 10 | 2020 | 22157 | 0.180 |
Why?
|
Placebos | 3 | 2018 | 1666 | 0.170 |
Why?
|
Double-Blind Method | 5 | 2018 | 12341 | 0.170 |
Why?
|
Proteome | 2 | 2020 | 1856 | 0.160 |
Why?
|
Alanine | 1 | 2022 | 608 | 0.160 |
Why?
|
Cardiovascular Diseases | 8 | 2024 | 15513 | 0.160 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2019 | 34 | 0.160 |
Why?
|
CD4 Lymphocyte Count | 5 | 2020 | 2569 | 0.160 |
Why?
|
Fats | 1 | 2019 | 99 | 0.160 |
Why?
|
Caspase 1 | 1 | 2019 | 226 | 0.150 |
Why?
|
Obesity, Abdominal | 2 | 2019 | 373 | 0.150 |
Why?
|
Glipizide | 2 | 2015 | 48 | 0.150 |
Why?
|
Alanine Transaminase | 1 | 2021 | 602 | 0.150 |
Why?
|
Risk Factors | 21 | 2024 | 74219 | 0.150 |
Why?
|
Proteomics | 3 | 2020 | 3836 | 0.140 |
Why?
|
Sex Factors | 7 | 2024 | 10552 | 0.140 |
Why?
|
Permeability | 1 | 2019 | 721 | 0.140 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.140 |
Why?
|
Drug Resistance, Viral | 2 | 2023 | 862 | 0.140 |
Why?
|
Ergolines | 2 | 2009 | 57 | 0.140 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2018 | 197 | 0.130 |
Why?
|
Galectin 3 | 1 | 2018 | 240 | 0.130 |
Why?
|
Viral Nonstructural Proteins | 1 | 2018 | 227 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4340 | 0.130 |
Why?
|
Subcutaneous Fat | 1 | 2019 | 393 | 0.130 |
Why?
|
Hyperprolactinemia | 2 | 2009 | 124 | 0.120 |
Why?
|
Galectins | 1 | 2018 | 296 | 0.120 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4538 | 0.120 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 1738 | 0.120 |
Why?
|
Body Mass Index | 7 | 2023 | 12951 | 0.110 |
Why?
|
Cytokines | 2 | 2019 | 7386 | 0.110 |
Why?
|
Disease | 1 | 2019 | 670 | 0.110 |
Why?
|
Pituitary Neoplasms | 2 | 2021 | 1323 | 0.110 |
Why?
|
Amino Acids, Aromatic | 1 | 2013 | 36 | 0.110 |
Why?
|
Liver | 2 | 2021 | 7513 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 9 | 2019 | 20600 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 674 | 0.110 |
Why?
|
Echocardiography, Stress | 1 | 2013 | 135 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 5 | 2021 | 2025 | 0.100 |
Why?
|
Osteoprotegerin | 1 | 2012 | 177 | 0.100 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4947 | 0.100 |
Why?
|
Cholesterol | 2 | 2014 | 2902 | 0.100 |
Why?
|
Weight Gain | 1 | 2022 | 2349 | 0.100 |
Why?
|
Diet | 3 | 2019 | 8047 | 0.100 |
Why?
|
Hypoglycemic Agents | 2 | 2015 | 3086 | 0.090 |
Why?
|
RNA, Viral | 1 | 2020 | 2839 | 0.090 |
Why?
|
Young Adult | 15 | 2021 | 59199 | 0.090 |
Why?
|
Waist Circumference | 2 | 2019 | 933 | 0.090 |
Why?
|
Cardiovascular System | 1 | 2018 | 836 | 0.090 |
Why?
|
Pharmacogenetics | 1 | 2015 | 675 | 0.090 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 269 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1893 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2019 | 64670 | 0.090 |
Why?
|
Hepacivirus | 1 | 2018 | 1330 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2015 | 735 | 0.090 |
Why?
|
Adolescent | 17 | 2021 | 88271 | 0.090 |
Why?
|
Mineralocorticoids | 1 | 2010 | 37 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 503 | 0.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2020 | 1895 | 0.090 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2553 | 0.090 |
Why?
|
Interleukin-6 | 2 | 2018 | 3210 | 0.090 |
Why?
|
Metformin | 2 | 2015 | 906 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4341 | 0.090 |
Why?
|
Triglycerides | 2 | 2009 | 2457 | 0.080 |
Why?
|
Cholesterol, LDL | 2 | 2018 | 2380 | 0.080 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 675 | 0.080 |
Why?
|
Prevalence | 7 | 2019 | 15717 | 0.080 |
Why?
|
Bone Marrow | 1 | 2019 | 2911 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3030 | 0.070 |
Why?
|
Insulin Resistance | 3 | 2019 | 3951 | 0.070 |
Why?
|
Hepatitis C | 1 | 2018 | 1579 | 0.070 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 15308 | 0.070 |
Why?
|
Heart Valves | 1 | 2009 | 284 | 0.070 |
Why?
|
Abdominal Fat | 1 | 2008 | 221 | 0.070 |
Why?
|
Drug Interactions | 1 | 2011 | 1417 | 0.070 |
Why?
|
Resistin | 1 | 2007 | 172 | 0.070 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 26068 | 0.070 |
Why?
|
Prospective Studies | 7 | 2021 | 54419 | 0.060 |
Why?
|
Angiography | 3 | 2016 | 1597 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2018 | 3048 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8529 | 0.060 |
Why?
|
Aorta | 1 | 2012 | 2040 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4431 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2081 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2008 | 941 | 0.060 |
Why?
|
Ultrasonography | 2 | 2008 | 5971 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2010 | 802 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4488 | 0.050 |
Why?
|
Risk Assessment | 5 | 2024 | 24013 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12058 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2010 | 1818 | 0.050 |
Why?
|
Hormones | 1 | 2006 | 869 | 0.050 |
Why?
|
Insulin | 3 | 2015 | 6588 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5478 | 0.050 |
Why?
|
Coronary Disease | 1 | 2016 | 5921 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5841 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2010 | 2160 | 0.040 |
Why?
|
CD4-CD8 Ratio | 1 | 2020 | 114 | 0.040 |
Why?
|
Neurobiology | 1 | 2021 | 137 | 0.040 |
Why?
|
California | 1 | 2024 | 1431 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6385 | 0.040 |
Why?
|
Dietary Fats | 1 | 2007 | 1995 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13630 | 0.040 |
Why?
|
Prognosis | 4 | 2024 | 29672 | 0.040 |
Why?
|
Oxazines | 1 | 2021 | 349 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3689 | 0.040 |
Why?
|
Aged | 11 | 2021 | 169266 | 0.040 |
Why?
|
Leptin | 1 | 2007 | 1595 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3803 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6507 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2638 | 0.040 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2021 | 287 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2019 | 211 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2006 | 6224 | 0.040 |
Why?
|
Mass Screening | 1 | 2013 | 5425 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2019 | 436 | 0.030 |
Why?
|
American Heart Association | 2 | 2014 | 1043 | 0.030 |
Why?
|
Tomography, X-Ray | 1 | 2016 | 60 | 0.030 |
Why?
|
Adipogenesis | 1 | 2019 | 365 | 0.030 |
Why?
|
Macrophages | 1 | 2011 | 5754 | 0.030 |
Why?
|
Muscle Cells | 1 | 2016 | 195 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2019 | 534 | 0.030 |
Why?
|
Hemodynamics | 1 | 2006 | 4164 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2019 | 466 | 0.030 |
Why?
|
Diet Surveys | 1 | 2019 | 1161 | 0.030 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2015 | 152 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3821 | 0.030 |
Why?
|
Methylamines | 1 | 2015 | 136 | 0.030 |
Why?
|
Uganda | 1 | 2019 | 1332 | 0.030 |
Why?
|
Positron-Emission Tomography | 3 | 2016 | 6585 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2019 | 1443 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3577 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2015 | 291 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14607 | 0.030 |
Why?
|
Choline | 1 | 2015 | 515 | 0.030 |
Why?
|
Quinolines | 1 | 2018 | 764 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8478 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1603 | 0.030 |
Why?
|
Adipocytes | 1 | 2019 | 1184 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 309 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2022 | 1812 | 0.030 |
Why?
|
Angiotensin II | 1 | 2015 | 848 | 0.020 |
Why?
|
Viral Proteins | 1 | 2019 | 1798 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2015 | 1178 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15845 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2021 | 80673 | 0.020 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 273 | 0.020 |
Why?
|
Treatment Failure | 1 | 2018 | 2643 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2290 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2013 | 449 | 0.020 |
Why?
|
Weight Loss | 1 | 2003 | 2680 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1867 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1790 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168083 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2181 | 0.020 |
Why?
|
Osteopontin | 1 | 2011 | 302 | 0.020 |
Why?
|
Markov Chains | 1 | 2013 | 965 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4109 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 602 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2009 | 106 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 174 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1553 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39121 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58946 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2277 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2227 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6305 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 21357 | 0.020 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2008 | 91 | 0.020 |
Why?
|
Body Constitution | 1 | 2007 | 273 | 0.020 |
Why?
|
Prolactin | 1 | 2009 | 625 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2016 | 1589 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9518 | 0.020 |
Why?
|
Quality of Life | 1 | 2008 | 13362 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2013 | 1723 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 41486 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2682 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2855 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9324 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13506 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1885 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 6178 | 0.010 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 293 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5869 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6857 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2492 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14676 | 0.010 |
Why?
|
United States | 3 | 2021 | 72337 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10213 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12983 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11475 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10514 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1336 | 0.010 |
Why?
|
Eating | 1 | 2009 | 1535 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5311 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5870 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5494 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18217 | 0.010 |
Why?
|
Energy Intake | 1 | 2007 | 2133 | 0.010 |
Why?
|
Anti-Obesity Agents | 1 | 2003 | 227 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2009 | 2877 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39953 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7400 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16572 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18385 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 5006 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15915 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7804 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17889 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81324 | 0.010 |
Why?
|
Concepts
(275)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_